Epidemiology and Treatment Strategy of Open Respiratory Phenotype in Critically Ill Patients
Conditions: Mechanical Ventilation Pressure High; Critical Illness Interventions: Other: pressure-volume curve with a low-flow insufflation of 5 L/min Sponsors: Southeast University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage ⅢA; Non-small Cell Lung Cancer Stage IIIB Interventions: Other: cycles of neoadjuvant therapy and duration of waiting for surgery Sponsors: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
The Constitution and Efficacy of Chinese Medicine of Infertility Male, Female, and Pregnant Female
Conditions: Infertility; Miscarriage Threatening Interventions: Drug: Chinese Herb Sponsors: China Medical University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis
Conditions: Bronchiectasis Adult Interventions: Device: Oscillation and Lung Expansion; Behavioral: Postural drainage; Drug: Anti-infective therapy; Drug: Mucolytic Sponsors: Shanghai Pulmonary Hospital, Shanghai, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy
Conditions: Cardiomyopathy, Hypertrophic Obstructive; Minimally Invasive Surgery Interventions: Procedure: thoracoscopic Morrow surgery; Procedure: modified Morrow surgery Sponsors: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Impact of Hepatectomy on HCC Recurrence
Conditions: Hepatocellular Carcinoma Stage I; Recurrence Interventions: Procedure: Major hepatectomy Sponsors: Anhui Medical University; National Natural Science Foundation of China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
The Effectiveness of Group-Delivered Revised Guided Written Exposure Therapy for PTSD and Subclinical PTSD Among Chinese Adolescents
Conditions: PTSD Interventions: Behavioral: Group-delivered guided written exposure therapy-revised version; Behavioral: Waiting-List (WL) condition Sponsors: Peking University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
TBP Survey Among Respiratory Physicians
Conditions: Pleural Effusion; Tuberculosis, Pleural Interventions: Other: Survey Sponsors: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Conditions: Obesity; Drug Interventions: Drug: Semaglutide; Drug: Placebo Sponsors: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Conditions: Varices; Liver Cirrhosis Interventions: Diagnostic Test: different diagnostic models Sponsors: Beijing 302 Hospital; Qianfoshan Hospital; First Hospital of China Medical University; The Second Affiliated Hospital of Dalian Medical University; The Second Norman Bethune Hospital of Jilin University; Shengjing Hospital; The Affiliated Hospital Of Guizhou Medical University; The First Hospital of Yulin; LanZhou University; Chengdu Third People ' s Hospital; Tianjin Third Central Hospital; Second Affiliated Hospital of Xi ' an Jiaotong University; People ' s Hospital of Lixin County; The Fourth People ' s Hospital o...
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy
Conditions: Oral Mucositis Interventions: Dietary Supplement: Lactobacillus rhamnosus GG powder; Dietary Supplement: Placebo-containing tablets; Radiation: Radiotherapy Sponsors: West China Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study
Conditions: RECTAL NEOPLASMS; Rectal Cancer Interventions: Radiation: Radiotherapy; Drug: Tislelizumab; Drug: Capecitabine; Drug: Oxaliplatin; Drug: Capecitabine Sponsors: Fudan University; Shanghai Zhongshan Hospital; Shanghai Changzheng Hospital; Huadong Hospital; RenJi Hospital; The Fourth Hospital of Hebei Medical University; First Hospital of China Medical University; Liaoning Cancer Hospital& Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
Conditions: Healthy Interventions: Drug: 9MW3011; Drug: 9MW3011 placebo Sponsors: Mabwell (Shanghai) Bioscience Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Conditions: Hepatocellular Carcinoma; Radiotherapy; Pembrolizumab; Tumor Thrombosis Interventions: Radiation: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy; Drug: Pembrolizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Endovascular Treatment for eXtra-Large Ischemic Stroke
Conditions: Stroke, Acute Ischemic Interventions: Drug: Medical management; Procedure: Endovascular thrombectomy Sponsors: Zhongming Qiu; The First Affiliated Hospital, University of South China; Xiangtan Central Hospital; Zhejiang University; Longyan First Affiliated Hospital of Fujian Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
